Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19

Technology

Highly Multiplexed Single-Cell Proteomics Identifies Key Inflammatory Mediators in Severe COVID-19

Featured Speaker: Victor Tek, Senior Product Manager, IsoPlexis

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Learn how IsoPlexis fills in the data gaps left by status quo proteomics, genomics & single-cell technologies

Explore each component of IsoPlexis' integrated system: bulk & single-cell chips solutions, automated benchtop instruments, and advanced software analysis

Review several published studies showing how our technology identified key inflammatory mediators in COVID-19

Explore Related Resources

Access related webinars, eBooks, app notes & case studies.

Webinar

Using Proteomics to Enable the Adaptive and Innate Immune Response in Vaccines against COVID-19

Paper Summary

Immune-cell Functional Profiling Sheds Light on the Pathogenesis of Severe COVID-19

Blog

COVID-19 Publication: Uncovering Cytokines Driving Neuroinflammation in COVID-19 Patients with IsoPlexis’ Unique Functional Proteomics

Watch the Webinar

Back to the Top